296
Views
26
CrossRef citations to date
0
Altmetric
Original Research

A top-down technique to improve the solubility and bioavailability of aceclofenac: in vitro and in vivo studies

, , , , &
Pages 4921-4935 | Published online: 11 Jul 2017

References

  • KuMSDulinWA biopharmaceutical classification-based Right-First-Time formulation approach to reduce human pharmacokinetic variability and project cycle time from First-In-Human to clinical Proof-Of-ConceptPharm Dev Technol201217328530221121705
  • KalepuSNekkantiVInsoluble drug delivery strategies: review of recent advances and business prospectsActa Pharm Sin B20155544245326579474
  • MekaAKPolaSTupallyKRAbbarajuPLDevelopment, evaluation and characterization of surface solid dispersion for solubility and dissolution enhancement of IrbesartanInt J Drug Dev Res201241263273
  • ThirupathaiahASunderRSFormulation and evaluation of simvastatin solid dispersions by solvent evaporation methodRes J Pharm Biol Chem20167425162528
  • SanphuiPDeviVKClaraDMalviyaNGangulySDesirajuGRCocrystals of hydrochlorothiazide: Solubility and diffusion/permeability enhancements through drug-coformer interactionsMol Pharm20151251615162225800383
  • GoodDJNaírRHSolubility advantage of pharmaceutical cocrystalsCryst Growth Des20099522522264
  • DarekarTAithalKSShirodkarRKumarLAttariZLewisSCharacterization and in vivo evaluation of lacidipine inclusion complexes with β-cyclodextrin and its derivativesJ Incl Phenom Macrocycl Chem2016843–4225235
  • JafarMAliSGhonaimHMImproved solubility and dissolution rate of ketoprofen by beta cyclodextrin ternary complexes incorporating hydrophilic polymersInt J Drug Deliv Technol2017714551
  • BlagdenNde MatasMGavanPTYorkPCrystal engineering of active pharmaceutical ingredients to improve solubility and dissolution ratesAdv Drug Deliv Rev200759761763017597252
  • LiHYPanTTCuiYImproved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion techniqueInt J Nanomedicine2016113777378827540291
  • NarayanRAttariZSreenivasa ReddyMKoteshwaraKBEnhanced solubility and bioavailability of pioglitazone nanosuspensionAdv Sci Lett2016224987994
  • KambleRNMehtaPPKumarAEfavirenz self-nano-emulsifying drug delivery system: in vitro and in vivo evaluationAAPS Pharm-SciTech201617512401247
  • BandiSSankaKBakshiVEnhanced oral delivery of risperidone through a novel self-nanoemulsifying powder (SNEP) formulations: in-vitro and ex-vivo assessmentJ Microencapsul201633654455327568868
  • TanYYangZPengXA novel bottom-up process to produce nanoparticles containing protein and peptide for suspension in hydrofluoroalkane propellantsInt J Pharm20114131–216717321527322
  • JunyaprasertVBMorakulBNanocrystals for enhancement of oral bioavailability of poorly water-soluble drugsAsian J Pharm Sci20151011323
  • YeXPatilHFengXConjugation of hot-melt extrusion with high-pressure homogenization: a novel method of continuously preparing nanocrystal solid dispersionsAAPS PharmSciTech2016171788826283197
  • Raghava SrivalliKMMishraBDrug nanocrystals: a way toward scale-upSaudi Pharm J201624438640427330370
  • MöschwitzerJPDrug nanocrystals in the commercial pharmaceutical development processInt J Pharm2013453114215623000841
  • JunghannsJUMüllerRHNanocrystal technology, drug delivery and clinical applicationsIntl J Nanomedicine200833295309
  • Van EerdenbrughBVermantJMartensJAA screening study of surface stabilization during the production of drug nanocrystalsJ Pharm Sci20099862091210318803265
  • ElsayedIAbdelbaryAAElshafeeyAHNanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteersInt J Nanomedicine2014912943295324971006
  • Van EerdenbrughBVan den MooterGAugustijnsPTop-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid productsInt J Pharm20083641647518721869
  • PatravaleVBDateAAKulkarniRMNanosuspensions: a promising drug delivery strategyJ Pharm Pharmacol200456782784015233860
  • Akkus ArslanSTirnaksizFA nonsteroidal anti-inflammatory drug: AceclofenacFABAD J Pharm Sci201035105118
  • MaulviFADalwadiSJThakkarVTSoniTGGohelMCGandhiTRImprovement of dissolution rate of aceclofenac by solid dispersion techniquePowder Tech20112071–34754
  • DuaKPabrejaKRamanaMVEnhancement of dissolution behavior of aceclofenac by complexation with β-cyclodextrin-choline dichloride coprecipitateJ Disp Sci Tech2011321014771484
  • RanpiseNSKulkarniNSMairPDRanadeANImprovement of water solubility and in vitro dissolution rate of aceclofenac by complexation with β-cyclodextrin and hydroxypropyl-β-cyclodextrinPharm Dev Tech20101516470
  • MutalikSAnjuPManojKUshaANEnhancement of dissolution rate and bioavailability of aceclofenac: A chitosan-based solvent change approachInt J Pharm20083501–227929017945447
  • ParkJJMeghaniNChoiJSLeeBJDevelopment and evaluation of decorated aceclofenac nanocrystalsColloids Surf B Biointerfaces201614320621227011350
  • PattnaikSSwainKManaswiniPFabrication of aceclofenac nanocrystals for improved dissolution: Process optimization and physicochemical characterizationJ Drug Deliv Sci Tech201529199209
  • PatnaikSAdithaSKRattanTKamisettiVAceclofenac-soluplus nanocomposites for increased bioavailabilitySoft Nanosci Letters2015521320
  • XuXKhanMABurgessDJA quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessmentInt J Pharm20114191–2525921787854
  • PatravaleVBDisouzaJIRustomjeeMPharmaceutical Product Development: Insights into Pharmaceutical Processes, Management and Regulatory AffairsNew York, NYCRC Press, Taylor & Francis Group2016
  • VoAQFengXPimparadeMDual-mechanism gastroretentive drug delivery system loaded with an amorphous solid dispersion prepared by hot-melt extrusionEur J Pharm Sci2017102718428257881
  • VoAQFengXMorottJTA novel floating controlled release drug delivery system prepared by hot-melt extrusionEur J Pharm Biopharm20169810812126643801
  • MasoumiHRFBasriMSamiunWSIzadiyanZLimCJEnhancement of encapsulation efficiency of nanoemulsion-containing aripiprazole for the treatment of schizophrenia using mixture experimental designInt J Nanomedicine2015106469647126508853
  • UshaANMutalikSReddyMSRanjithAKKushtagiPUdupaNPreparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomeratesEur J Pharm Biopharm200870267468318606224
  • LohZHSamantaAKSia HengPWOverview of milling techniques for improving the solubility of poorly water-soluble drugsAsian J Pharml Sci2014104255274
  • RamasamyTTranTHChoiJYLayer-by-layer coated lipid–polymer hybrid nanoparticles designedfor use in anticancer drug deliveryCarbohydr Polym201410265366124507332
  • RamasamyTRuttalaHBChitrapriyaNEngineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumorsActa Biomaterialia20174813114327794477
  • RamasamyTRuttalaHBKanuBGSmart chemistry-based nanosized drug delivery systems for systemic applications: a comprehensive reviewJ Control Rel Epub201751
  • LiJKWangNWuXSPoly(vinyl alcohol) nanoparticles prepared by freezing–thawing process for protein/peptide drug deliveryJ Control Release1998561–31171269801435
  • NarayananKSubrahmanyamVMVenkata RaoJA fractional factorial design to study the effect of process variables on the preparation of hyaluronidase loaded PLGA nanoparticlesEnzyme Res2014201416296225574384
  • SjöbergMBergströmLLarssonASjöströmEThe effect of polymer and surfactant adsorption on the colloidal stability and rheology of kaolin dispersionsColloids Surf A Physicochem Eng Aspects19991591197208
  • RachmawatiHRahmaAAl ShaalLMüllerRHKeckCMDestabilization mechanism of ionic surfactant on curcumin nanocrystal against electrolytesScientia Pharmaceutica201684468569327763572
  • TefasLRTomuţăIAchimMVlaseLDevelopment and optimization of quercetin-loaded plga nanoparticles by experimental designClujul Medical201588221422326528074
  • SharmaNMadanPLinSEffect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: a co-surfactant studyAsian J Pharm Sci2016113404416
  • ShinHLeeSSuk JungHKimJBEffect of ball size and powder loading on the milling efficiency of a laboratory-scale wet ball millCeramics Int201339889638968
  • PeltonenLHirvonenJPharmaceutical nanocrystals by nanomilling: Critical process parameters, particle fracturing and stabilization methodsJ Pharm Pharmacol201062111569157921039542
  • ParadkarARPawarAPChordiyaJKPatilVBKetkarARSpherical crystallization of celecoxibDrug Dev Ind Pharm200228101213122012476867
  • CirriMMaestrelliFFurlanettoSMuraPSolid-state characterization of glyburide-cyclodextrin co-ground productsJ Thermal Analysis Calorimetry2004772413422
  • CortiGMaestrelliFCirriMMuraPZerroukNDissolution and permeation properties of naproxen from solid-state systems with chitosanDrug Deliv200815530331218763161
  • KhadkaPRoJKimHPharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailabilityAsian J Pharm Sci201496304316
  • JainSSharmaJMJainAKMahajanRRSurface-stabilized lopinavir nanoparticles enhance oral bioavailability without coadministration of ritonavirNanomedicine (Lond)20138101639165523351133